 |
Biosketch
CURRICULUM VITAE
William J. Tremaine, M.D.
PERSONAL:
Date of Birth: July 11, 1950
Place of Birth: Jackson, Mississippi
PROFESSIONAL ADDRESS: Division of Gastroenterology
Mayo Clinic
200 First Street Southwest
Rochester, Minnesota 55905
Telephone: (507)-284-2469
Fax: (507)-266-0335
PRESENT POSITION: Consultant
Internal Medicine and Gastroenterology
Mayo Clinic, Medical School,
and Foundation
Director, Mayo Foundation Office of Human Research Protection
Rochester, Minnesota
PRESENT ACADEMIC RANK: Professor of Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota 55905
EDUCATION:
1972 B.A. Vanderbilt University
Nashville, Tennessee
1976 M.D. University of Mississippi
School of Medicine
Jackson, Mississippi
CERTIFICATION AND LICENSURE:
1977 Diplomate of The National Board
of Medical Examiners
State of Minnesota,
No. 23, 670
1979 Diplomate of The American
Board of Internal Medicine,
No. 71539
1981 Diplomate of The Subspecialty of
Gastroenterology,
No. 71539
CLINICAL AND ACADEMIC APPOINTMENTS:
1976 - 1979 Resident, Department of
Medicine,
Mayo Graduate School of
Medicine
Rochester, Minnesota 55905
(E.C. Rosenow III, M.D.,
Program Director)
1979 - 1981 Fellow, Division of
Gastroenterology
Mayo Graduate School of
Medicine
Rochester, Minnesota 55905
(E.R. Dickson, M.D.,
Program Director)
1981 - 1994 Assistant Professor of Medicine
Mayo Medical School
Mayo Clinic
1981 - Consultant Division of
Gastroenterology
Department of Internal Medicine
Mayo Clinic
1991 - 2003 Director, Inflammatory Bowel
Disease Interest Group
2003- Head, IBD Clinic
Mayo Clinic
1994 - 2001 Associate Professor of Medicine
Mayo Medical School
Mayo Clinic
2001- Professor of Medicine
Mayo Medical School
Mayo Clinic
2002- Director, Mayo Clinic Office of Human Research Protection
HONORS AND AWARDS:
1976 Merck Award for outstanding performance in medicine; University of Mississippi
School of Medicine; Alpha Omega Alpha Honor Medical Society; University of Mississippi School of Medicine; Phi Eta Sigma Honor Society
1981 J. Arnold Bargen Award for Outstanding Achievement as a Subspecialty Trainee in Gastroenterology; Mayo Graduate School of Medicine
1988 Fellow of The American College of Physicians (FACP)
1991 American Medical Association Certificate of Appreciation: Drug Evaluations
2002 Fellow, American College of Gastroenterology;
2002 Henry S. Plummer Distinguished Physician Award, Department of Medicine
SOCIETIES:
1976 Alpha Omega Alpha
1979 American College of Physicians
1981 American Gastroenterological Association
1987 Society of Sigma XI
1990 Crohn's and Colitis Foundation of America
1993 Minnesota Medical Association; American Medical Association
2002 American College of Gastroenterology
RESEARCH SUPPORT:
1983 - 1984 Co-Investigator, Reid Rowell Pharmaceuticals: Placebo-Controlled Trial of 5-aminosalicylic acid Enemas in Ulcerative Proctosigmoiditis
1984 - 1992 Co-Investigator, Tillot'ts Labs (England) and Norwich Eaton Pharmaceuticals: Oral 5-aminosalicylic acid in the Treatment of Ulcerative Colitis, Collagenous Colitis, and Crohn's Disease
1989 - 1992 Principal Investigator, Norwich Eaton Pharmaceuticals/Proctor & Gamble Pharmaceuticals: Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Asacol in the Treatment of Symptomatic Crohn's Colitis and Crohn's Ileocolitis
1989 - 1990 Principal Investigator, Mayo Foundation Research Committee: Pilot Study using Short Chain Fatty Acid Enemas in the Treatment of Ileoanal Pouchitis
1991 - 1992 Co-Investigator, Sandoz Pharmaceuticals: Cyclosporine Enemas for Ulcerative Proctosigmoiditis. Oral Cyclosporine for Treatment of Crohn's Disease
1992 - 1994 Co-Investigator, ELAN Pharmaceuticals: A Randomized, Placebo-Controlled Trial of the Addition of the Transdermal Nicotine Patch to Current Therapy for Mildly to Moderate Active Ulcerative Colitis in LifetimeNon-Smokers and Ex-Smokers
1993 - 1996 Principal Investigator, Tillot'ts Pharma AG (Switzerland): Bismuth Foam Enemas For the Treatment of Chronic Pouchitis
1994 - 1995 Site Principal Investigator, Centocor: Phase II Multicenter Study of Anti-TNF Chimeric Antibody (cA2) in the Treatment of Patients with Ulcerative Colitis
1994 - 1998 Site Principal Investigator, Schering-Plough Research Institute: Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of Multiple Doses of Intravenous rhuIL-10 (SCH 52,000) in patients with Steroid Refractory Crohn's Disease
1995 – 1998 Principal Investigator, Astra Merck: Budesonide Controlled Ileal Relief Capsules Once or Twice Daily in Active Crohn’s Disease. A Placebo Controlled Study
1996 - 2000 Principal Investigator, Solvay Pharmaceuticals Strategic Alliance: Development of Guidelines for Clinical Practice in Inflammatory Bowel Disease
1996 – 1999 Principal Investigator, Astra Merck: Treatment of Gastroduodenal Crohn’s Disease with Omeprazole: A Multicenter, Blinded, Randomized Placebo Controlled Trial
1999 Principal Investigator, Merck and Company: A Placebo Controlled Trial of Alendronate for the Prevention of Osteoporosis in Patients with Inflammatory Bowel Disease
1999 Principal Investigator, Axys Pharmaceuticals: National Open-Label, Two Stage Pilot Study to Determine the Study, Tolerability, Steady-State Pharmacokinetics and Potential Efficacy of Subcutaneous APL 2059 for Patients With Mild to Moderate Active Ulcerative Colitis
2001-2002 Principal Invesigator; AstraZeneca Pharmaceuticals: Multicenter Trial Comparing Budesonide with Placebo in the Treatment of Active Crohn's
2004- PI, Late Onset IBD, Procter & Gamble Pharmaceutical
2006- Prevention of Progression of Left-sided UC. Procter & Gamble Pharm.
Adhoc Reviewer for Grant Applications
1997 - Veterans Administration
2000 - 2005 The Wellcome Trust, 183 Euston Road, London, NW1 2BE, UK
2002- Broad Medical Research Program
EDITORIAL AND REVIEW ACTIVITIES:
1994 - Section Co-editor, Editorial Board, Inflammatory Bowel Disease
1998 - Editorial Board, Mayo Clinic Proceedings; Editorial Board, Mayo Health Oasis, Internet Web Site
1999 - Editorial Board Member, Alimentary Pharmacology & Therapeutics
2000- Section Editor, Inflammatory Bowel Diseases
2001- 2002 Associate Editor, Mayo Clinic Proceedings
Ad hoc Reviewer for Journals - Gastroenterology, Mayo Clinic Proceedings, Journal of The American Medical Association, American Journal of Gastroenterology, Southern Medical Journal, Journal of Laboratory and Clinical Medicine, European Journal of Gastroenterology Disease of the Colon and Rectum, Gut
RECENT EXTRAMURAL LECTURE PRESENTATIONS
2004 Visiting Faculty Lecturer, LA County Hospital, USC, Los Angeles, CA
2004 Visiting Faculty Lecturer, UCLA, Los Angeles, CA.
2003 Visiting Faculty Lecturer, Rush Presbyterian St Lukes Medical Center, Chicago, Il
2003 Visiting Faculty Lecturer, Mt Sinai Medical Center, New York, NY
VISITING PROFESSORSHIPS
1998 Visiting Professor, Division of Gastroenterology, Yale University , New Haven, Connecticut
1999 Visiting Professor, Division of Gastroenterology, University of Connecticut, Farmington, Connecticut
1999 Visiting Professor, Division of Gastroenterology, St. Louis University, St. Louis, Missouri
2000 Visiting Professor, Division of Gastroenterology, Case Western University, Cleveland, Ohio
2004 Visiting Professor, Division of Gastroenterology, Vanderbilt University, Nashville, TN
2005 Visiting Professor, Division of Gastroenterology, Stanford University, Palo Alto, CA
EDUCATION:
Medical School Curriculum:
1983 - 1992 Protein Digestion and Metabolism. In: Digestive Disease Systems Course, Year I Curriculum
1985 - 1991 Physical Diagnosis, Gastroenterology Section Year II Curriculum
Graduate School Curriculum:
1982 - 1989 Intestinal Malabsorption. In: Internal Medicine Board Review Update
1992 Course Director, Mayo Division of Gastroenterology Continuing Education Course, Inflammatory Bowel Disease: Clinical Update, Rochester, Minnesota
1993 Course Director, Combined Mayo Foundation and Crohn's and Colitis Foundation of America Continuing Education Course. Inflammatory Bowel Disease: Clinical Cases
1998-1999 Course Director, IBD Update, Rochester, Minnesota
2000-2002 Course Director, Mayo IBD Clinical Practice Conferences
COMMITTEES:
Intramural:
1982 - 1986 Transfusion Committee
1981 - 1993 Internal Medicine Resident, Advisory Committee
1985 - 1990 GI Division, Recruitment Committee
1990 - 1993 GI Division, Executive Committee
1991 GI Division, Subspecialty Directors Committee
1992 - 1993 Mayo Foundation Hospital, Policy Committee
1993 - 1998 GI Division, Research Committee
1998 – 2002 Editorial Board, Mayo Clinic Proceedings, Editorial Board, Mayo Health Oasis, Internet Web Site
2002- Director, Mayo Clinic Office of Human Research Protection
Extramural:
1993 - 1999 National Scientific Advisory Committee, Crohn's and Colitis Foundation of America
1993 - 1996 Chair, Professional Education Committee, Crohn's and Colitis Foundation of America
1993 - 1999 Board of Directors, Minnesota Chapter, Crohn's and Colitis Foundation of America
1994 - present Member, IBD Forum Committee
1996 – 1999 Chair, Professional Affairs Committee, Crohn's and Colitis
Foundation of America
1998 Temporary Voting Member, FDA Gastrointestinal Drug Advisory
Committee, Bethesda, Maryland
2002 - 2005 Chair, IBD Forum Committee
2005 Chair, Review Panel. NIH IBD Genetics Consortium
2001 - present Member, Grants Review Committee, CCFA
CLINICAL PRACTICE:
Gastroenterology, with a primary interest in inflammatory bowel disease, Internal Medicine
|